Intent Data Providers for Medical Device ABM: Bombora, G2, and More

The Role of Intent Data in Medical Device ABM

Account-based marketing for medical devices operates on a fundamental premise: engage the right accounts at the right time with the right message. Intent data is what makes the "right time" part possible. Without it, your ABM program is essentially guessing when target accounts are actively evaluating solutions in your device category.

Intent data captures digital research signals that indicate an organization is exploring topics related to your product category. When multiple employees at a hospital system start researching "robotic-assisted surgical platforms" or "next-generation imaging systems," that collective behavior signals active buying intent. For medical device companies, where sales cycles routinely stretch 12 to 24 months, identifying these signals early can mean the difference between leading a competitive evaluation and scrambling to catch up after a competitor has already been shortlisted.

The intent data market has matured significantly. Providers like Bombora, 6sense, Demandbase, TechTarget, and G2 offer increasingly sophisticated signals that go beyond simple keyword matching. For medical device companies, however, the application of intent data requires industry-specific considerations: healthcare organizations have unique digital footprints, medical content consumption patterns differ from technology research, and regulatory factors influence how devices are evaluated.

This guide evaluates the leading intent data providers through a medical device lens, examines how to integrate intent data into your ABM workflows, and addresses the practical challenges of using intent signals in healthcare marketing.

How Intent Data Works in Healthcare B2B

Intent data comes from several sources, each with different strengths and limitations for medical device applications.

First-Party Intent Data

First-party intent data comes from your own digital properties: website visits, content downloads, webinar registrations, email engagement, and product page views. This data is the most reliable because you control the source, but it only captures behavior from accounts that have already found you.

For medical device companies, first-party intent signals include:

• Visits to product specification pages or clinical evidence sections of your website
• Downloads of white papers, case studies, or clinical summaries
• Attendance at your webinars or virtual educational events
• Engagement with email campaigns, particularly clicks on clinical data links
• Requests for pricing, demos, or product samples through web forms
• Multiple visitors from the same hospital IP address viewing product content

The limitation of first-party data is coverage. It only captures intent from accounts that are already aware of your brand. Accounts researching your device category but visiting competitor websites or third-party resources remain invisible.

Second-Party Intent Data

Second-party data is another organization's first-party data that they share or sell. In healthcare, this includes publisher data from medical journals, healthcare news sites, and clinical education platforms. When a hospital administrator reads an article about "capital equipment budgeting best practices" on a healthcare business publication, that reading behavior is captured as intent data.

Relevant second-party data sources for medical devices include:

• Medical journal publisher data (engagement with articles about device categories, clinical techniques, or treatment approaches)
• Healthcare business publication data (engagement with articles about purchasing, capital planning, or operational efficiency)
• Conference and webinar platform data (attendance and engagement at relevant medical education events)
• Review and comparison site data (activity on healthcare technology evaluation platforms)

Third-Party Intent Data

Third-party intent data is aggregated from a cooperative network of publishers, data partners, and web sources to identify organizations showing increased research activity around specific topics. This is the broadest form of intent data and the primary product offered by major intent data providers.

Third-party data identifies "surge" intent: when an organization's research activity on a topic exceeds its baseline level. A hospital that normally generates 10 content consumption events per week related to surgical instrumentation, and suddenly generates 40, is showing surge intent that likely indicates an active evaluation process.

Evaluating Intent Data Providers for Medical Devices

Not all intent data providers are equally suited for medical device ABM. Here is an evaluation of the leading platforms with specific attention to healthcare applicability.

Bombora

Bombora operates the largest B2B intent data cooperative, aggregating content consumption data from over 5,000 premium publisher websites. Their Company Surge methodology identifies accounts showing abnormal spikes in research activity across specific topic categories.

Strengths for medical devices:

• Broad publisher network includes several healthcare and medical publications
• Topic taxonomy covers clinical, operational, and technology topics relevant to medical devices
• Integration with major ABM and advertising platforms (Demandbase, 6sense, LinkedIn, and others)
• Strong data governance and privacy compliance
• Company Surge scoring makes it easy to prioritize accounts showing the highest intent

Limitations for medical devices:

• Publisher network skews toward technology and business content; healthcare-specific coverage is moderate
• Topic categories may not be granular enough for niche medical device categories (e.g., differentiating between general orthopedic surgery interest and specific joint replacement technology research)
• Account identification can be challenging for healthcare organizations where multiple departments share IP infrastructure

Pricing: Typically $25,000 to $60,000 annually depending on account volume and integration requirements.

6sense

6sense combines intent data with AI-powered predictive analytics to identify accounts that are "in-market" for specific product categories. Their Revenue AI platform integrates intent signals, technographic data, and behavioral patterns to generate buying stage predictions.

Strengths for medical devices:

• Predictive buying stage model goes beyond raw intent signals to estimate where accounts are in their purchasing journey
• Combines multiple data sources (intent, technographic, firmographic) into a unified account score
• Advertising capabilities enable serving ads to in-market accounts across display, social, and email channels
• Dynamic segmentation automatically adjusts account priorities as intent signals change
• Strong integration with Salesforce and major marketing automation platforms

Limitations for medical devices:

• Pricing is premium, typically $60,000 to $150,000+ annually, which may be challenging for smaller medical device companies
• Predictive models are trained primarily on technology purchasing patterns; healthcare procurement processes may not be fully captured
• Implementation requires significant data integration effort and ongoing optimization

Demandbase

Demandbase offers an ABM platform that combines account identification, intent data, advertising, and sales intelligence. Their "One" platform aims to unify marketing and sales engagement around account-level insights.

Strengths for medical devices:

• IP-based account identification is particularly valuable for targeting users at hospital facilities where organizational IP ranges are identifiable
• Combined advertising and intent capabilities allow you to both identify and reach in-market accounts
• Account-level engagement analytics across website, advertising, and sales touchpoints
• Strong personalization capabilities for website content and advertising creative

Limitations for medical devices:

• IP identification accuracy can vary for healthcare organizations with complex network architectures, shared service centers, or cloud-based infrastructure
• Healthcare-specific intent taxonomy is limited compared to technology categories
• Full platform deployment is complex and resource-intensive

Pricing: Typically $50,000 to $120,000+ annually for the full platform.

TechTarget Priority Engine

TechTarget captures intent signals from its network of technology-focused media properties. Their Priority Engine product delivers account-level and contact-level intent data for technology categories.

Strengths for medical devices:

• Contact-level intent data (most providers only offer account-level) enables direct outreach to individuals showing research behavior
• Strong coverage for health IT and connected medical device categories
• Content syndication capabilities pair well with intent data for lead generation

Limitations for medical devices:

• Primarily focused on technology topics; limited coverage for clinical device categories that do not have an IT component
• Publisher network is technology-centric, so non-IT medical device signals may be sparse

G2 Buyer Intent

G2 captures intent from its software review platform, identifying organizations researching specific product categories through review reading, comparison activity, and category browsing.

Relevance for medical devices: Limited. G2's coverage is primarily software and SaaS. However, for medical device companies that sell software-based solutions (clinical decision support, surgical planning software, device management platforms), G2 intent data can be a relevant supplementary source.

Healthcare-Specific Intent Signal Sources

Beyond the major intent data platforms, medical device companies should consider healthcare-specific signal sources that the general platforms may miss:

• FDA database monitoring: Track 510(k) submissions, PMA applications, and recall notices in your device category. Competitors filing new submissions or receiving clearances triggers evaluation activity at potential customers.
• Clinical trial registries: ClinicalTrials.gov data reveals which institutions are participating in trials related to your device category, indicating clinical interest and potential adoption readiness.
• GPO contract databases: Monitoring contract award dates and renewal cycles for your device category reveals purchasing windows at specific health systems.
• Hospital capital expenditure filings: Some states require healthcare facilities to file Certificates of Need for major capital equipment purchases, providing early warning of buying activity.
• Medical conference attendance: Tracking which accounts send attendees to specialty conferences where your device category is featured indicates active interest and education-gathering.
• PubMed publication patterns: When physicians at a target account begin publishing research related to your device's clinical application, it often precedes an institutional adoption decision.

For a broader perspective on reaching healthcare buyers through organic channels, explore how healthcare SEO works alongside intent data to capture demand across the buying journey.

Integrating Intent Data into Medical Device ABM Workflows

Raw intent data is only valuable if it triggers action. Here is how to operationalize intent signals within your medical device ABM program:

Account Prioritization

Use intent data to dynamically adjust your target account tiers. An account showing surge intent should be elevated in priority, even if its static firmographic score places it in Tier 2. Conversely, a Tier 1 account showing no intent signals may need a different engagement approach (awareness-building rather than conversion-focused).

Create an intent-influenced scoring model that combines your existing ICP score with real-time intent signals. For example:

• ICP score accounts for 60% of the composite score (firmographic fit, procedure volume, financial health)
• Intent signals account for 40% of the composite score (topic relevance, surge intensity, number of signals, recency)

This blended approach prevents you from chasing every account that shows a momentary spike in research activity while ensuring you act on genuine buying signals from high-fit accounts.

Sales Activation

Configure your intent data platform to deliver actionable alerts to sales reps when target accounts show meaningful intent signals. The alert should include:

• Which account is showing intent
• What topics they are researching
• How the current signal compares to their baseline activity
• Recommended next action (e.g., "Call Dr. [Name] in Orthopedics to discuss their research on [topic]")
• Relevant content to share based on the topics being researched

Timing matters enormously. Intent signals have a half-life. An account showing surge intent today will be less receptive in 30 days when they have already formed opinions or progressed in their evaluation. Sales should respond to high-priority intent alerts within 24 to 48 hours.

Content Personalization

Use intent signals to personalize the content experience for target accounts. If an account is researching "total cost of ownership" topics, serve them economic analysis content. If they are researching clinical outcomes, serve them peer-reviewed evidence. This alignment between what the account is interested in and what you present creates a more relevant experience.

Website personalization tools can display different content to visitors from target accounts based on their intent profile. A visitor from an account showing clinical intent sees case studies and outcome data on your homepage. A visitor from an account showing financial intent sees ROI calculators and cost comparison tools.

Advertising Targeting

Intent data significantly improves the efficiency of your ABM advertising by focusing ad spend on accounts actively in-market. Rather than serving display ads to all 500 accounts on your target list, concentrate budget on the 50 to 75 showing active intent signals. This approach typically improves advertising ROI by 3x to 5x compared to static list targeting.

Both Demandbase and 6sense offer built-in advertising capabilities that use intent data for targeting. Alternatively, export intent-qualified account lists to LinkedIn Campaign Manager or programmatic platforms for targeted campaigns.

Challenges of Intent Data in Healthcare

While intent data is valuable for medical device ABM, several healthcare-specific challenges require attention:

Account Identification Accuracy

Healthcare organizations have complex network architectures. Academic medical centers, in particular, may share IP infrastructure with affiliated universities, research institutes, and physician practice groups. This can lead to misattribution of intent signals. An intent signal attributed to "Johns Hopkins Health System" might actually originate from the university's School of Public Health or an affiliated community practice.

Mitigation: Cross-reference intent signals with other data sources. An intent signal gains credibility when combined with first-party engagement (the account visited your website) or sales intelligence (the rep confirms active evaluation activity).

Topic Granularity

Medical device categories can be highly specific. A company selling a particular type of spinal fusion implant needs intent data about that specific device category, not about orthopedic surgery in general. Most intent data providers' topic taxonomies are not granular enough for niche medical device categories.

Mitigation: Work with your intent data provider to create custom topic clusters that map to your specific device category. Combine multiple related topics to create a composite signal that approximates the granularity you need.

Long Sales Cycles and Signal Interpretation

Medical device sales cycles are long, and buying activity is not continuous. A hospital might show intent signals during an initial research phase, go quiet for six months during internal budget discussions, and then show signals again when they are ready to evaluate specific products. Interpreting intent signals within this context requires understanding of healthcare purchasing timelines.

Mitigation: Track intent signals over longer windows (90 to 180 days rather than 7 to 14 days) to account for the episodic nature of medical device research. Maintain engagement during quiet periods through educational content that keeps your brand visible without pressuring for action.

Regulatory Sensitivity

Intent data in healthcare intersects with data privacy regulations including HIPAA. While intent data typically operates at the organizational level and does not involve protected health information, be cautious about combining intent data with patient-level or physician-level data in ways that could create compliance issues.

Mitigation: Work with your legal and compliance teams to establish data handling policies specific to intent data in healthcare contexts. Ensure your data processing agreements with intent data providers address healthcare-specific privacy requirements.

Building an Intent Data Strategy: Step by Step

Here is a practical roadmap for implementing intent data in your medical device ABM program:

• Step 1: Audit your first-party data. Before investing in third-party intent data, maximize the value of your own website, email, and event engagement data. Implement IP-to-account resolution on your website (tools like Clearbit Reveal or Demandbase) to identify which target accounts are already visiting.
• Step 2: Define your intent topic taxonomy. Work with your clinical marketing team to define the topics that indicate buying intent for your specific device category. These should include clinical topics (procedures, techniques, conditions), operational topics (efficiency, cost reduction, workflow), and competitive topics (competitor device names, product comparisons).
• Step 3: Select a primary intent data provider. Based on the evaluation criteria above, choose the provider that best matches your device category, budget, and technology stack. For most medical device companies, Bombora or 6sense provides the best starting point.
• Step 4: Integrate with your CRM and marketing automation. Intent data must flow into the systems your teams use daily. Configure bidirectional integrations so intent signals appear in Salesforce account records and trigger automated marketing workflows.
• Step 5: Build response playbooks. Define what happens when an account shows intent. Who is notified? What content is served? What outreach is triggered? Without response playbooks, intent data becomes interesting but not actionable.
• Step 6: Measure and optimize. Track the correlation between intent signals and downstream outcomes (meetings, pipeline, revenue). Refine your topic taxonomy and response playbooks based on what you learn.

For a comprehensive framework on building your overall medical device marketing strategy, including how intent data fits within the broader go-to-market approach, explore our specialized services for medical device companies.

ROI of Intent Data for Medical Device ABM

The ROI of intent data is driven by two primary mechanisms: increased efficiency (spending resources on accounts more likely to buy) and improved timing (engaging accounts when they are receptive).

Industry benchmarks suggest that intent-driven ABM programs achieve:

• 2x to 3x higher engagement rates with target accounts compared to non-intent-driven outreach
• 30% to 50% improvement in sales-accepted lead quality
• 25% to 40% reduction in sales cycle length for intent-identified accounts
• 3x to 5x improvement in advertising ROI when spend is focused on in-market accounts

For a medical device company spending $200,000 annually on ABM campaigns, shifting to intent-driven targeting could yield the equivalent of $600,000 to $1 million in campaign effectiveness, not through increased spending but through better allocation of existing resources.

The key is sustained implementation. Intent data delivers compounding returns as you refine your topic taxonomy, build response playbooks, and train your sales team to act on signals quickly. Companies that treat intent data as a "set it and forget it" tool miss the ongoing optimization that drives the strongest results. For guidance on how to approach this as part of a broader medical device marketing strategy, our comprehensive guide covers the full landscape.